Yazar "Baltasar, F" seçeneğine göre listele
Listeleniyor 1 - 5 / 5
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Clinical and laboratory validation of the 2nd International Standard of low molecular weight heparin (IS 2003-01/608) in the anti-Xa. Anti-LIA heptest and prothrombinase induced clotting (PiCT) tests(Amer Soc Hematology, 2005) Hoppensteadt, D; Jeske, W; Fareed, D; Baltasar, F; Walenga, JM; Tobu, M; Demir, M[Abstract Not Available]Öğe Comparative study on the anticoagulant effects of low molecular weight heparins as measured by whole blood ACT, anti-Xa and a newly developed prothrombinase induced clotting time (PiCT) assay(Amer Soc Hematology, 2005) Hoppensteadt, D; Tobu, M; Wahi, R; Iqbal, O; Walenga, JM; Demir, M; Baltasar, F[Abstract Not Available]Öğe Frequency of anti-erythropoietin antibodies in patients with end stage renal disease treated with recombinant erythropoietin(Amer Soc Hematology, 2005) Hoppensteadt, D; Tobu, M; Fareed, D; Iqbal, O; Baltasar, F; Patel, C; Bansal, V[Abstract Not Available]Öğe Molecular heterogeneity in recombinant erythropoietin using surface enhanced laser induced desorption ionization (SELDI). clinical implications(Amer Soc Hematology, 2005) James, E; Maddineni, J; Fareed, J; Florian-Kujawski, M; Baltasar, F; Jeske, W; Hoppensteadt, D[Abstract Not Available]Öğe Potential role of ADAMTS13/FXI complexes in the pathogenesis of end stage rental disease(Amer Soc Hematology, 2005) Fareed, J; Hoppensteadt, D; Cunanan, J; Patel, C; Maddineni, J; Baltasar, F; Fareed, D[Abstract Not Available]
